Citation Impact
Citing Papers
A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling
2007 StandoutNobel
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy
2001 StandoutNobel
Coronary artery bifurcation interventions: The disconnect between randomized clinical trials and patient centered decision‐making
2011
Physical and mechanical properties of PLA, and their functions in widespread applications — A comprehensive review
2016 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Regional Systems of Care for Out-of-Hospital Cardiac Arrest
2010
A rationale for the use of β-blockers as standard treatment for heart failure
2000
HRS Expert Consensus Statement on the Diagnosis and Management of Arrhythmias Associated With Cardiac Sarcoidosis
2014 Standout
Anti–β1-adrenergic receptor antibodies and heart failure: causation, not just correlation
2004 StandoutNobel
Invasive coronary treatment strategies for out-of-hospital cardiac arrest: a consensus statement from the European Association for Percutaneous Cardiovascular Interventions (EAPCI)/Stent for Life (SFL) groups
2014
Prognosis determination in heart failure
2001
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Ten-year experience of an invasive cardiology centre with out-of-hospital cardiac arrest patients admitted for urgent coronary angiography
2014
Mitochondria: In Sickness and in Health
2012 Standout
European Resuscitation Council Guidelines for Resuscitation 2010 Section 10. The ethics of resuscitation and end-of-life decisions
2010
Therapeutic potential of β-arrestin- and G protein-biased agonists
2010 StandoutNobel
Myocarditis
2011 Standout
Differential cardioprotective/cardiotoxic effects mediated by β-adrenergic receptor subtypes
2005 StandoutNobel
European Resuscitation Council Guidelines for Resuscitation 2010 Section 4. Adult advanced life support
2010 Standout
Effects of Multisite Biventricular Pacing in Patients with Heart Failure and Intraventricular Conduction Delay
2001 Standout
A Randomized Clinical Study Comparing Double Kissing Crush With Provisional Stenting for Treatment of Coronary Bifurcation Lesions
2011
Part 12: Education, implementation, and teams
2010
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)
2005 Standout
Atrial fibrillation: current knowledge and recommendations for management*1
1998
Predicting Mortality Among Patients Hospitalized for Heart Failure
2003 Standout
Immediate coronary angiogram in comatose survivors of out-of-hospital cardiac arrest—An Australian study
2011
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
Phytosterols, phytostanols, and their conjugates in foods: structural diversity, quantitative analysis, and health-promoting uses
2002 Standout
Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling
2000 Standout
Coronary Stents
2010
Linkage of β1-adrenergic stimulation to apoptotic heart cell death through protein kinase A–independent activation of Ca2+/calmodulin kinase II
2003 StandoutNobel
Impact of Percutaneous Coronary Intervention Performance Reporting on Cardiac Resuscitation Centers
2013
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease
2008 Standout
Part 9: Post–Cardiac Arrest Care
2010 Standout
Neurohormonal Activation and the Chronic Heart Failure Syndrome in Adults With Congenital Heart Disease
2002
Abnormal cardiac function associated with sympathetic nervous system hyperactivity in mice
2002 StandoutNobel
Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy
2020 Standout
Prediction of protein function and pathways in the genome era
2004
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
β-Adrenergic Receptor Blockade in Chronic Heart Failure
2000
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension
2003 Standout
Classification of Intrinsically Disordered Regions and Proteins
2014 Standout
Linkage of β1-adrenergic stimulation to apoptotic heart cell death through protein kinase A–independent activation of Ca2+/calmodulin kinase II
2003 StandoutNobel
Randomized Trial of Simple Versus Complex Drug-Eluting Stenting for Bifurcation Lesions
2010
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Part 8: Post–Cardiac Arrest Care
2015 Standout
Right Ventricular Function in Cardiovascular Disease, Part I
2008 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Anti–β1-adrenergic receptor antibodies and heart failure: causation, not just correlation
2004 StandoutNobel
Heart Failure and Echocardiographic Changes During Long-term Follow-up of Patients With Sick Sinus Syndrome Randomized to Single-Chamber Atrial or Ventricular Pacing
1998
Dual-Chamber Versus Ventricular Pacing
1996
Cardiac Sarcoidosis and Giant Cell Myocarditis as Causes of Atrioventricular Block in Young and Middle-Aged Adults
2011
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Prospective, Randomized Comparison of Effect of Long-Term Treatment With Metoprolol or Carvedilol on Symptoms, Exercise, Ejection Fraction, and Oxidative Stress in Heart Failure
1999
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Part 8: Adult Advanced Cardiovascular Life Support
2010 Standout
Predictors of Survival From Out-of-Hospital Cardiac Arrest
2009 Standout
Works of Roberto Zanini being referenced
Emergency percutaneous coronary intervention in patients with ST-elevation myocardial infarction complicated by out-of-hospital cardiac arrest: Early and medium-term outcome
2008
Survival Rates after Pacemaker Implantation: A Study of Patients Paced for Sick Sinus Syndrome and Atrioventricuiar Block
1989
Comparative effects of metoprolol and carvedilol on resting and peak exercise hemodynamics and functional capacity in patients with chronic heart failure.
1997
Effects of neurohormonal antagonism on symptoms and quality-of-life in heart failure.
1998
Randomized Study of the Crush Technique Versus Provisional Side-Branch Stenting in True Coronary Bifurcations
2008
Morbidity and Mortality of Patients with Sinus Node Disease: Comparative Effects of Atrial and Ventricular Pacing
1990